 | • レポートコード：D0-MOR-AP1208 • 出版社/出版日：Mordor Intelligence / 2020年4月20日 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：健康管理 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、網膜硝子体手術装置の世界市場について調査・分析した資料で、網膜硝子体手術装置の市場概要、動向、セグメント別市場規模、地域別分析、競争状況、企業情報、市場機会分析などで構成されています。 |
The vitreoretinal surgery devices market is projected to grow with a CAGR of 6.6% over the forecast period. The major factor attributing to the growth of the market is the rising incidence of eye disorders like macular degeneration, retinal detachment, uveitis and vitreous hemorrhage, macular hole, epiretinal membrane, retinal detachment, and complications related to diabetic retinopathy. Furthermore, the increasing geriatric population who are more prone to the eye disorders is boosting the market growth. Technological developments observed in the field and the increased availability of automated and easy-to-use devices is further boosting the growth of the market.
Key Market Trends
Posterior Vitreoretinal Surgery is Expected to Grow at a Faster Rate in the Forecast Period
The dominant share of the segment is attributed to the increasing posterior viteroretinal procedures. In rare cases, the vitreous gel comes through the pupil into the anterior chamber of the eye only then anterior vitreoretinal surgeries are done. Increasing eye disorders and increasing geriatric population is further boosting the segment growth.
According to The International Agency for the Prevention of Blindness, it is estimated that globally 196 million people will have age related macular degeneration (AMD) by the year 2020, increasing to 288 million in 2040. The major risk factors for AMD are age, genetic factors and tobacco smoking. Therefore, increasing geriatric population also plays a important role in the segment growth
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the overall vitreoretinal surgery devices market, throughout the forecast period. The largest share is mainly due to the presence of larger patient pool and increasing geriatric population. In North America region, the United States holds the largest market share due to the factors such as increasing geriatric population, along with a growing number of patient pool in the country. According to Brightfocus Foundation, approximately 11 million people in the United States have some form of age-related macular degeneration in 2019. This number is expected to double to nearly 22 million by 2050. As per the statistics the large patient pool and high disposable income propels the market growth in the region.
Competitive Landscape
The Vitreoretinal Surgery Devices market is moderately competetive. A few of the crucial approaches followed by players functioning in the market are, product advancement, invention, acquisitions and mergers. Some of the companies which are currently domianting the market are Dutch Ophthalmic Research Center International BV, Bausch & Lomb, Inc., OCULUS Optikgeräte GmbH, Paragon Care Group Australia Pty Ltd, and MedOne Surgical, Inc.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidence of Eye Disorders
4.2.2 Increasing Geriatric Population
4.3 Market Restraints
4.3.1 Side Effects of the Procedures
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Per Fluoro Carbon Liquids
5.1.2 Endoillumination Instruments
5.1.3 Vitreo Retinal Prefilled Silicone Oil Syringes
5.1.4 Others
5.2 By Surgery Type
5.2.1 Anterior Vitreoretinal Surgery
5.2.2 Posterior Vitreoretinal Surgery
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Dutch Ophthalmic Research Center International BV
6.1.2 Bausch & Lomb, Inc.
6.1.3 OCULUS Optikgerete GmbH
6.1.4 Paragon Care Group Australia Pty Ltd
6.1.5 MedOne Surgical, Inc
6.1.6 Alcon
6.1.7 Carl Zeiss
6.1.8 Topcon Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS